Background: In neurally mediated syncope a ‘typical’ EEG pattern during hyperventilation (HV) may be observed. This study aimed to investigate transcranial Doppler (TCD) and EEG variations in response to hyper- and hypocapnia using simultaneous recording. Methods: Syncope patients with a typical EEG pattern during HV (SEEG+, n = 15) and those without abnormalities (SEEG–, n = 16) were compared with healthy controls (n = 20). Simultaneous TCD and EEG recordings were performed at rest (baseline), during 2 apnea tests and during HV. Cerebrovascular vasoreactivity, index for hypocapnia, total vasomotor reserve and time to flow velocity normalization after HV (t-norm) were recorded. Results: With TCD, a reduction in Vasomotor reserve was observed in SEEG+ compared with the other 2 groups (control: 67 ± 8%; SEEG–: 67 ± 10%; SEEG+: 57 ± 8%; p < 0.0001). t-norm was longer in all syncopal patients and in particular in SEEG+ (control: 20.2 ± 3 s; SEEG–: 40 ± 7 s; SEEG+: 123 ± 45s; p < 0.0001). Quantitative EEG showed an increase in slow bands in all subjects during HV, small and nonsignificant in controls and SEEG–, higher and significant in SEEG+, related with flow reduction. Conclusions: Changes in the sympathetic modulation of cerebral vasoconstriction may explain both the pathophysiology of vasovagal syncope and the typical paroxysmal EEG findings.

Keywords:
Syncope, Transcranial Doppler, Quantitative EEG, Cerebral vasoreactivity
1.
Mathias CJ, Deguchi K, Schalz I: Observations on recurrent syncope and presyncope in 641 patients. Lancet 2001;357:348–353.
2.
Lempert T, Bauer M, Schmidt D: Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 1994;36:233–237.
3.
Abubakr A, Wambacq I: The diagnostic value of EEGs in patients with syncope. Epilepsy Behav 2005;6:433–434.
4.
Mecarelli O, Pulitano P, Vicenzini E, Vanacore N, Accornero N, De Marinis M: Observations on EEG patterns in neurally mediated syncope: an inspective and quantitative study. Neurophysiol Clin 2004;34:203–207.
5.
Patel VM, Maulsby RL: How hyperventilation alters the electroencephalogram: a review of controversial viewpoints emphasizing neurophysiological mechanisms. J Clin Neurophysiol 1987;4:101–120.
6.
Hennerici MG: Intracranial cerebral arteries; in Hennerici MG, Neuerburg-Heusler D (eds): Vascular Diagnosis with Ultrasound. Clinical References with Case Studies. Stuttgart, Thieme, 2006, pp 89–138.
7.
Lagi A, Cencetti S, Corsoni V, Georgiadis D, Bacalli S: Cerebral vasoconstriction in vasovagal syncope: any link with symptoms? A transcranial Doppler study. Circulation 2001;27:2694–2698.
8.
Silvani S, Padoan G, Guidi AR, Bianchedi G, Maresta A: Cerebral vasoconstriction in neurally mediated syncope: relationship with type of head-up tilt test response. Ital Heart J 2003;4:768–775.
9.
Ladwig S, Ries S, Henning O, Valikovics A, Daffertshofer M, Pohlmann-Eden B: Combined electroencephalography and measurements of transcranial blood flow velocity during orthostatic testing – a new approach to assess syncope of unknown origin? Clin Auton Res 1997;7:305–309.
10.
Lindegaard KF, Grolimund P, Aaslid R, Nornes H: Evaluation of cerebral AVM’s using transcranial Doppler ultrasound. J Neurosurg 1986;65:335–344.
11.
Ringelstein EB, Sievers C, Ecker S, Schneider PA, Otis SM: Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. Stroke 1988;19:963–969.
12.
Mecarelli O, Piacenti A, Pulitano P, Vicenzini E, Rizzo C, Rinalduzzi S, de Feo MR, Accornero N: Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers. Clin Neuropharmacol 2001;24:284–289.
13.
Brenner RP: Electroencephalography in syncope. J Clin Neurophysiol 1997;14:197–209.
14.
Gastaut H, Fischer-Williams M: Electro-encephalographic study of syncope; its differentiation from epilepsy. Lancet 1957;2:1018–1025.
© 2008 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.